Delivery Order SPE2DB20D1100-SPE2DB24FD9D2

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,985.27 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a specialty medication, with a period of performance through March 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a specialty medication, at a firm fixed price of $13,622.60. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a $12,606.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $17,809.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of Taltz 80 mg/mL autoinjectors, a specialty medication. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies for military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,975.18, is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has a completion date of July 24, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,500.35, is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of March 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a $8,592.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
This is a $15,267.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Taltz 80 mg/mL autoinjectors, a specialty medication, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,564.72 firm-fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that...
This is a $21,241.62 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the pharmaceutical product TALTZ 80 MG/ML AUTOINJECTORML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by DLA and other agencies to supply a wide range of essential medical products and prescription...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD9D2
    Delivery Order

This is a $8,719.78 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TALTZ 80 MG/ML AUTOINJECTOR, a specialty medication used to treat various medical conditions. This order is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999, for delivering a range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of September 19, 2024, and was awarded on September 18, 2024. No set-aside designation is indicated.

Generated 12/18/24, 9:39 AM